King Wealth Management Group
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1568235
SARATOGA SPRINGS, NY
Position in TEVA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,388,000
+$74,800 QoQ
Shares Held
100,000
-9.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#219
of 673 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026King Wealth Management Group holds $5,636,594 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (60.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
100,000 | $3,388,000 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
4,150 | $2,248,594 |
All Filings in TEVA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,388,000 | 100,000 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $3,313,200 | 110,000 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $4,213,350 | 135,000 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,232,000 | 160,000 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $3,435,800 | 205,000 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,689,750 | 175,000 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $3,196 | 14,500 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,767,798 | 98,102 | Shares | Sole | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||